Connect with us

Business

CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine: Bloomberg News – Investing.com

CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine: Bloomberg News

Published

on

post featured image
ADVERTISEMENT

(Reuters) – AstraZeneca (NASDAQ:AZN) is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage, its chief executive was quoted as saying on Thursday amid questions over the results from its late-stage study.
Instead of adding the trial to an ongoing U.S. process, AstraZeneca might launch a fresh study to evaluate a lower dosage of its vaccine that performed better than a full dosage, Pascal Soriot was quoted as saying in a Bloomberg News report.

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
We look at a Ethereum as a crypto-cloud stock and the next possible step of cloud computing: Fundstrat Strategist – Yahoo Finance
post featured image
Mega Millions jackpot increases to $970 million – NBC News
post featured image
If You Bought Tesla Stock Instead Of A Model S At Launch, Here’s How Much You’d Have Now – Benzinga